Concepedia

Publication | Open Access

LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target

88

Citations

49

References

2020

Year

Abstract

LGR5 has distinct roles in ER<sup>-</sup> vs. ER<sup>+</sup> BC with potential clinical applicability as a biomarker to identify patients in need of therapy and could serve as a therapeutic target for high-grade ER<sup>-</sup> BC.

References

YearCitations

Page 1